351 related articles for article (PubMed ID: 17503533)
21. Photo-crosslinkable, thermo-sensitive and biodegradable pluronic hydrogels for sustained release of protein.
Lee JB; Yoon JJ; Lee DS; Park TG
J Biomater Sci Polym Ed; 2004; 15(12):1571-83. PubMed ID: 15696801
[TBL] [Abstract][Full Text] [Related]
22. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.
Chinen N; Tanihara M; Nakagawa M; Shinozaki K; Yamamoto E; Mizushima Y; Suzuki Y
J Biomed Mater Res A; 2003 Oct; 67(1):61-8. PubMed ID: 14517862
[TBL] [Abstract][Full Text] [Related]
23. Injectable and sustained delivery of human growth hormone using chemically modified Pluronic copolymer hydrogels.
Park SY; Chung HJ; Lee Y; Park TG
Biotechnol J; 2008 May; 3(5):669-75. PubMed ID: 18246570
[TBL] [Abstract][Full Text] [Related]
24. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
Peattie RA; Rieke ER; Hewett EM; Fisher RJ; Shu XZ; Prestwich GD
Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
[TBL] [Abstract][Full Text] [Related]
25. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
[TBL] [Abstract][Full Text] [Related]
27. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors.
Briganti E; Spiller D; Mirtelli C; Kull S; Counoupas C; Losi P; Senesi S; Di Stefano R; Soldani G
J Control Release; 2010 Feb; 142(1):14-21. PubMed ID: 19811766
[TBL] [Abstract][Full Text] [Related]
28. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
29. Release kinetics and in vitro bioactivity of basic fibroblast growth factor: effect of the thickness of fibrous matrices.
Kim MS; Shin YM; Lee JH; Kim SI; Nam YS; Shin CS; Shin H
Macromol Biosci; 2011 Jan; 11(1):122-30. PubMed ID: 20886548
[TBL] [Abstract][Full Text] [Related]
30. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis.
Kimura Y; Tabata Y
J Biomater Sci Polym Ed; 2010; 21(1):37-51. PubMed ID: 20040152
[TBL] [Abstract][Full Text] [Related]
31. Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors.
Losi P; Briganti E; Magera A; Spiller D; Ristori C; Battolla B; Balderi M; Kull S; Balbarini A; Di Stefano R; Soldani G
Biomaterials; 2010 Jul; 31(20):5336-44. PubMed ID: 20381861
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates.
Cho YI; Park S; Jeong SY; Yoo HS
Eur J Pharm Biopharm; 2009 Sep; 73(1):59-65. PubMed ID: 19409990
[TBL] [Abstract][Full Text] [Related]
33. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds.
Andreopoulos FM; Persaud I
Biomaterials; 2006 Apr; 27(11):2468-76. PubMed ID: 16321436
[TBL] [Abstract][Full Text] [Related]
34. Neovascularization by bFGF releasing hyaluronic acid-gelatin microspheres: in vitro and in vivo studies.
Demirdögen B; Elçin AE; Elçin YM
Growth Factors; 2010 Dec; 28(6):426-36. PubMed ID: 20854186
[TBL] [Abstract][Full Text] [Related]
35. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
36. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration.
DeLong SA; Moon JJ; West JL
Biomaterials; 2005 Jun; 26(16):3227-34. PubMed ID: 15603817
[TBL] [Abstract][Full Text] [Related]
37. Tetronic-oligolactide-heparin hydrogel as a multi-functional scaffold for tissue regeneration.
Go DH; Joung YK; Lee SY; Lee MC; Park KD
Macromol Biosci; 2008 Dec; 8(12):1152-60. PubMed ID: 18698580
[TBL] [Abstract][Full Text] [Related]
38. Arginine functionalization of hydrogels for heparin binding--a supramolecular approach to developing a pro-angiogenic biomaterial.
Gilmore L; Rimmer S; McArthur SL; Mittar S; Sun D; MacNeil S
Biotechnol Bioeng; 2013 Jan; 110(1):296-317. PubMed ID: 22753043
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of a biodegradable gelatin hydrogel sponge sheet on the progression of experimental abdominal aortic aneurysms.
Miyama N; Sato A; Matsubara M; Watanabe T; Ikada Y; Satomi S
Ann Vasc Surg; 2009 Mar; 23(2):224-30. PubMed ID: 18783914
[TBL] [Abstract][Full Text] [Related]
40. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis.
Yang HS; Bhang SH; Hwang JW; Kim DI; Kim BS
Tissue Eng Part A; 2010 Jun; 16(6):2113-9. PubMed ID: 20136400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
